Filing Flows › Omada Health (OMDA) › Q3 2026
Omada Health (OMDA) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 6, 2026
Omada Health (OMDA) reported revenue of $91.3M for the third quarter 2026 (Q3 2026), +34% from a year earlier and +4% from the quarter before. Operating margin was 5.3%, net earnings $6.6M (7.2% of revenue).
Omada Health, Q3 2026: revenue $91.3M (+34% year over year), operating margin 5.3%, net earnings $6.6M, operating cash flow $15.1M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $91.3M | +4% | +34% |
| Gross profit | $69.3M | +9% | +54% |
| Operating profit | $4.8M | +36% | — |
| Net earnings | $6.6M | +24% | — |
| Operating cash flow | $15.1M | +278% | +49% |
| Free cash flow | $15.0M | +289% | +57% |
What changed
Revenue was $91.3M in Q3 2026, up 34% year over year and up 4% from the previous quarter. Services was the largest line at 93% of revenue. Services added $22.2M year over year (up 35%), 95% of the total change.
Gross margin was 75.9%, up 9.6 points from Q3 2025. Operating profit was $4.8M, a 5.3% margin (up 9.0 points year over year). Operating expenses grew 35% against revenue growth of 34%. The fastest-growing cost line was Research & development (+48%). Net earnings were $6.6M. The effective tax rate was 0.0%. Non-operating items added $1.7M, 26% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $15.1M (up 49% year over year), 231% of net earnings. Non-cash charges added back $1.7M of depreciation and amortization and $5.9M of share-based compensation. Working capital and other items added $1.1M. Capital expenditures of $118K left free cash flow of $15.0M.
Questions
What was Omada Health's revenue in the third quarter 2026?
Omada Health (OMDA) reported revenue of $91.3M for the third quarter 2026 (Q3 2026), +34% from a year earlier and +4% from the quarter before.
Was Omada Health profitable in the third quarter 2026?
Operating profit was $4.8M (5.3% of revenue) and net earnings $6.6M.
Source: Omada Health 10-Q on SEC EDGAR.